This webinar will discuss how frameworks for cell and gene therapy commercialisation can be designed, how clinical trials can be appropriately structured and how the product candidates can be successfully commercialized in the target markets.
Cell and gene therapy applications have, in the last three years, made the jump from pure research products to commercialized products with high clinical efficacy, particularly for hematologic malignancies. In order to facilitate further development of cell and gene therapies for other diseases, such as solid cancers and inherited diseases, it will be important to define a framework for such undertakings, and choose the right path for eventual commercialization of successful products. This webinar will discuss how such programs can be designed, how clinical trials can be appropriately structured and how the product candidates can be successfully commercialized in the target markets. Case examples will be presented, and an overview of the current international developments in the cell and gene therapy field will be given.
Dr Jacqueline Barry, Chief Clinical Officer
Challenges with Implementation of Clinical Trials Across Multiple Geographies
Find out more and how to register for this webinar here